공시 • Dec 19
PURE Bioscience, Inc., Annual General Meeting, Feb 17, 2026 PURE Bioscience, Inc., Annual General Meeting, Feb 17, 2026. Location: springhill suites huntington beach orange county, 7872 edinger avenue, ca 92647., huntington beach United States 공시 • Nov 20
PURE Bioscience, Inc. Announces Executive Changes PURE Bioscience, Inc. announced that the Company has appointed Jeff Kitchell as President, in addition to his ongoing responsibilities as Corporate Secretary, and Dolana Blount as Vice President of Operations, in addition to her ongoing responsibilities as Vice President of Regulatory Affairs, in each case, effective as of November 17, 2025. Robert Bartlett will continue in his role as a Board Member and Chief Executive Officer, but will step down as President. The decision to separate the President and CEO roles allows Mr. Bartlett to devote his attention more exclusively to his responsibilities as CEO. Mr. Kitchell brings more than 24 years of experience with PURE, having served in multiple leadership roles, including most recently as Vice President of Operations. His deep operational expertise and long-standing dedication to the Company position him well to guide PURE’s next phase of execution and strategic development. Ms. Blount, a 27-year veteran of the Company, has held numerous leadership positions and played a significant role in the Company’s intellectual property and product development. Her expanded responsibilities reflect her strong operational capabilities and continued leadership across critical areas of the business. 공시 • Jun 03
PURE Bioscience, Inc. Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry PURE Bioscience, Inc. announced an innovative application method for membrane treatment in the dairy and beverage industry using PURE®? Hard Surface. This solution addresses common membrane fouling and sanitization challenges, delivering outstanding results that enable operators to restore throughput and sanitize the membrane without damage or oxidation. Key Attributes of PURE Hard Surface for Membrane Treatment: One Treatment--Zero Compromises: Achieve superior results with just one treatment. PURE Hard Surface effectively removes fouling, restores flow, and delays the need for membrane replacement without compromising membrane integrity. Proven Performance: The solution boasts results with successful treatments demonstrating an impressive 4+ log reduction in 120 seconds. Additionally, it is NSF-listed, making it ideal for eliminating harmful bacteria in the dairy industry without causing membrane oxidation. Complete Penetration in Minutes: In practical applications, treatment has shown complete membrane penetration within 5 minutes for reverse osmosis (RO) systems, effectively scrubbing away fouling and restoring throughput. Similarly, ultrafiltration treatment (UF) systems resulted in immediate penetration and unmatched restoration of throughput while sanitizing to meet stringent quality specifications. Simplicity and Effectiveness: Membrane operators prefer PURE Hard Surface for its no-hassle approach. The ready-to-use formula requires no mixing--fill and go. Plus, with the lowest EPA toxicity rating, there is no need for personal protective equipment, making it highly safe for staff. Environmentally Safe: treatment poses no risks to wastewater systems, ensuring no impact on digesters or discharge permit compliance. Cost-Effective Solution: With just one treatment, manufacturers can sell full-priced finished goods, reduce operational costs, and significantly prolong the lifespan of their membranes, contributing to overall operational efficiency. 공시 • Dec 13
PURE Bioscience, Inc., Annual General Meeting, Jan 22, 2025 PURE Bioscience, Inc., Annual General Meeting, Jan 22, 2025. Location: springhill suites huntington beach orange county, 7872 edinger avenue, ca 92647, huntington beach United States 공시 • May 08
PURE Bioscience Appoints Darin Zehr to Board of Directors PURE Bioscience, Inc. reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1, 2024. Mr. Zehr joins as an independent director and will also serve as a member of PURE’s Audit Committee and Compensation Committee. Mr. Zehr brings extensive experience working in the food industry. Since 1990, he has held various roles in food quality and safety, sanitation, and operations management. He is the General Manager of Commercial Food Sanitation LLC (CFS). CFS, an Intralox Company, is a global food safety consulting and training organization that works across all food industry segments and has operations in North and South America, Europe, Asia, and Australia. Prior to this role, Mr. Zehr spent 22 years with Kraft Foods where he held numerous roles in operations, including Area Sanitation Manager, Business Unit Manager, and Plant Manager. He is Treasurer of the Board of Directors for Beaver Camp, a non-profit Christian Camping establishment, a former board member of the New York State Cheese Manufacturer’s Association, and former board member of the Lewis County General Hospital. Mr. Zehr received a Bachelor of Science degree in Chemistry from The State University of New York (SUNY) at Oswego. He lives in Northern New York with his wife of 30 years and has three adult children. 공시 • Jan 11
PURE Bioscience, Inc., Annual General Meeting, Feb 21, 2024 PURE Bioscience, Inc., Annual General Meeting, Feb 21, 2024, at 10:30 Pacific Standard Time. Location: SpringHill Suites Huntington Beach Orange County - 7872 Edinger Avenue Huntington Beach California United States Agenda: To elect six directors; to ratify the appointment of Weinberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending July 31, 2024; to approve, on a non-binding advisory basis, the compensation of named executive officers, during the fiscal year ended July 31, 2023; to approve the PURE Bioscience, Inc. 2024 Equity Incentive Plan; and to approve an amendment Certificate of Incorporation to increase the authorized number of shares of common stock from 150,000,000 shares to 200,000,000 shares.